4//SEC Filing
Vuori Kristiina MD 4
Accession 0001739614-22-000063
CIK 0001739614other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:34 PM ET
Size
5.4 KB
Accession
0001739614-22-000063
Insider Transaction Report
Form 4
Inhibrx, Inc.INBX
Vuori Kristiina MD
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-25+15,000→ 45,000 totalExercise: $12.57Exp: 2032-05-25→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
Inhibrx, Inc.
CIK 0001739614
Entity typeother
Related Parties
1- filerCIK 0001612627
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:34 PM ET
- Size
- 5.4 KB